|
|
 |
|
| Home > Product > Product Information |
|
|
|
 Ahngook Cilostazol tab. |
|
|
|
|
|
|
|
|
|
 |
|
inhibits platelet aggregation and is a direct arterial vasodilator |
|
 |
|
Treatment of intermittent claudication |
|
 |
|
Cilostazol |
|
 |
|
|
|
 |
|
Ethical the Counter(ETC) |
|
 |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
1) Composition
Cilostazol------------50mg
2) Dosage and Administration
100mg twice a day
3) Indications
Cilostazol is approved for the treatment of intermittent claudication. The typical dose is 100 mg twice a day. The effects may take as much as 3 months to be evident.
4) Mechanism of action
Cilostazol is a selective cAMP phosphodiesterase inhibitor. It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation
5) Stroage
tight container, at room temperature
6) Expiry date
36 months from manufactured date
|
|
|
|
 |
|
|
